在患有慢性心力衰竭的老鼠中,Xijiaqi Formula通过抑制神经炎症和促进神经可塑性来减轻认知功能障碍
Jie Chen1, Xuefen Wu1, Qian Zhang1
1Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Chinese journal of natural medicines
|January 22, 2026
概括
奇佳奇配方 (XJQ) 通过减少神经炎症和通过PDE4/cAMP通路增强突触可塑性,改善慢性心力衰竭 (CHF) 鼠的认知功能.
科学领域:
- 心血管医学 心血管医学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性心力衰竭 (CHF) 与认知障碍有关.
- 传统中医药Xijiaqi配方 (XJQ) 用于心脏梗塞,可以改善认知能力.
- 在治疗心衰竭后认知功能障碍时,XJQ的精确机制尚未完全理解.
研究的目的:
- 为了研究XJQ对CHF大鼠认知功能障碍的影响.
- 阐明XJQ治疗作用的潜在分子机制.
主要方法:
- 在老鼠中诱导了CHF;随后接受了XJQ治疗.
- 评估心脏和认知功能使用心声回声学,血液动力学参数,莫里斯水迷宫和开放场测试.
- 网络药理学,分子对接和生物化学分析被用来识别活性成分和信号通路.
主要成果:
- 在CHF大鼠中,XJQ治疗改善了心脏和认知功能.
- XJQ调节了突触功能,炎症以及PDE4/cAMP信号通路.
- 通过影响cAMP通路中的关键蛋白质,XJQ抑制了微质和天体细胞激活,减少了促炎性细胞因子,并促进了突触修复.
- 特定的XJQ组件直接与PDE4.4结合.
结论:
- 在CHF大鼠中,XJQ缓解神经炎症并增强突触可塑性.
- XJQ对认知功能障碍的治疗作用通过PDE4/cAMP/PKA/CREB信号通路进行介导.
- 这项研究提供了关于心脑轴和XJQ用于治疗CHF相关认知问题的药理基础的见解.
相关概念视频
Heart Failure II: Pathophysiology
798
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
798
Pathophysiology of Heart Failure
3.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction
737
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
737
Transcription Attenuation in Prokaryotes
18.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.2K
Chemical Formulas
61.0K
A chemical formula presents information about the proportions of atoms constituting a particular chemical compound or molecule, mainly using symbols of elements and numbers. At times other symbols, such as dashes, parentheses, brackets, commas, plus, and minus signs, are also used. A chemical formula can be one of three types – molecular, empirical, and structural.
61.0K
Heart Failure VI: Adjunct Therapies
280
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280


